NAUT earnings date and last-quarter result: next report 2026-07-28, last quarter beat, P/E -3.70. Updated 2026-07-23.
Nautilus Biotechnolgy (NAUT) Research Hub
Nautilus Biotechnolgy (NAUT) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.44 USD (-24.69%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.70, market cap 0.22B. This hub links to the full technical, earnings and options research available for NAUT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.44 USD (-24.69%) |
| 52-week range | 0.841 USD – 3.26 USD |
| Trend regime | Range |
| 14-day RSI | 59.5 (Bullish) |
| Trailing P/E | -3.70 |
| Market cap | 0.22B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-28 |
Available research for NAUT
Covered Call on NAUT: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on NAUT: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on NAUT: how it works, illustrative setup around the real 2.44 USD price, max profit/loss, breakeven and when to use it. Educational.
NAUT technical analysis: range, last 2.44 USD, RSI 59.5, 52w range 0.841 USD–3.26 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is NAUT in?
Nautilus Biotechnolgy (NAUT) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is NAUT in an uptrend or downtrend?
As of 2026-10-26, NAUT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is NAUT's trailing P/E ratio?
NAUT's trailing P/E is -3.70, with a market cap of 0.22B. See the earnings research page for full valuation detail.
When does NAUT next report earnings?
NAUT is next scheduled to report earnings on 2026-07-28.